Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus

European Journal of Endocrinology

Volumn 162, Issue 6, 2010, Pages 1101-1105

  Sahakyan, Karine ^a   Klein, Barbara E K ^a   Lee, Kristine E ^a   Tsai, Michael Y ^b   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME VARIABLE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; FEMALE; HOMOCYSTEINE; HUMANS; INCIDENCE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROTEINURIA; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77952720849     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0049     Document Type: Article

References (21)

1. Parving HH, Hovind P, Rossing K & Andersen S. Evolving strategies for renoprotection: diabetic nephropathy. Current Opinion in Nephrology and Hypertension 2001 10 515-522. (Pubitemid 32664704)
2. Krempf M. Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes. Néphrologie & Thérapeutique 2006 2 S190-S192.
3. Stitt AW, Jenkins AJ & Cooper ME. Advanced glycation end products and diabetic complications. Expert Opinion on Investigational Drugs 2002 11 1205-1223.
4. Rossing P. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus. Diabetic Medicine 1998 15 900-919. (Pubitemid 28500243)
5. Navarro JF, Mora C, Maca M & Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 2003 42 53-61. (Pubitemid 36807654)
6. Kang ES, Kim HJ, Ahn CW, Park CW, Cha BS, Lim SK, Kim KR & Lee HC. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Research and Clinical Practice 2005 69 151-159. (Pubitemid 40943480)
7. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH & Rossing P. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008 31 1170-1176.
8. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM & Schaumberg DA. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care 2008 31 2338-2343.
9. Klein R, Klein BE, Moss SE, DeMets DL, Kaufman I & Voss PS. Prevalence of diabetes mellitus in Southern Wisconsin. American Journal of Epidemiology 1984 119 54-61. (Pubitemid 14220346)
10. Klein R, Klein BE, Moss SE, Davis MD & DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology 1984 102 520-526.
11. Klein R, Klein BE, Moss SE & Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Archives of Ophthalmology 1994 112 1217-1228.
12. Klein R, Knudtson MD, Lee KE, Gangnon R & Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008 115 1859-1868.
13. Klein R, Klein BE, Moss SE, Davis MD & DeMets DL. TheWisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology 1989 107 237-243.
14. Mysliwiec M, Balcerska A, Zorena K, Mysliwska J, Nowacka M, Lipowski P & Raczynska K. Selected immunologic and biochemical risk factors of the retinopathy and nephropathy development in children with diabetes mellitus type 1. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego 2006 12 269-273. (Pubitemid 46033207)
15. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ & Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002 51 1157-1165. (Pubitemid 34438363)
16. Nakahara C, Kanemoto K, Saito N, Oyake Y, Kamoda T, Nagata M & Matsui A. C-reactive protein frequently localizes in the kidney in glomerular diseases. Clinical Nephrology 2001 55 365-370. (Pubitemid 32427918)
17. Schwedler SB, Guderian F, Dammrich J, Potempa LA & Wanner C. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrology, Dialysis, Transplantation 2003 18 2300-2307.
18. Wotherspoon F, Laight DW, Browne DL, Turner C, Meeking DR, Allard SE, Munday LJ, Shaw KM & Cummings MH. Plasma homocysteine, oxidative stress and endothelial function in patients with type 1 diabetes mellitus and microalbuminuria. Diabetic Medicine 2006 23 1350-1356. (Pubitemid 44787800)
19. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P & Nawroth PP. Hyperhomocyst(e) inemia and endothelial dysfunction in IDDM. Diabetes Care 1998 21 841-848.
20. Unlucerci Y, Bekpinar S, Gurdol F & Seferoglu G. A study on the relationship between homocysteine and diabetic nephropathy in rats. Pharmacological Research 2002 45 249-252. (Pubitemid 35428789)
21. Zelmanovitz T, Gross JL, Oliveira J & de Azevedo MJ. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy. Diabetes Care 1998 21 1076-1079. (Pubitemid 28368511)